NeuroPace Inc financial data

Symbol
NPCE on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
455 N. Bernardo Avenue, Mountain View, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 623 % -31.3%
Quick Ratio 79.9 % -14.5%
Debt-to-equity 553 % +122%
Return On Equity -195 % -46%
Return On Assets -29.9 % +22%
Operating Margin -34.5 % +47.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.2M shares +12.9%
Common Stock, Shares, Outstanding 29.1M shares +12.9%
Entity Public Float 65.9M USD +31.8%
Common Stock, Value, Issued 29K USD +11.5%
Weighted Average Number of Shares Outstanding, Basic 28.9M shares +13.3%
Weighted Average Number of Shares Outstanding, Diluted 28.9M shares +13.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 71.8M USD +30.8%
Research and Development Expense 22M USD +3.36%
Operating Income (Loss) -24.8M USD +31.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -29.9M USD +29.5%
Earnings Per Share, Basic -1.08 USD/shares +36.1%
Earnings Per Share, Diluted -1.08 USD/shares +36.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.8M USD +63.5%
Cash, Cash Equivalents, and Short-term Investments 55.5M USD -12.7%
Accounts Receivable, after Allowance for Credit Loss, Current 11.2M USD +3.37%
Inventory, Net 11.4M USD +13.5%
Assets, Current 80.2M USD -7.27%
Property, Plant and Equipment, Net 998K USD +2.25%
Operating Lease, Right-of-Use Asset 12.6M USD -10.6%
Other Assets, Noncurrent 15K USD -28.6%
Assets 94.4M USD -7.67%
Accounts Payable, Current 2.29M USD +26.7%
Employee-related Liabilities, Current 6.3M USD -5.11%
Accrued Liabilities, Current 7.75M USD -5.34%
Contract with Customer, Liability, Current 809K USD
Liabilities, Current 12.6M USD +9.36%
Operating Lease, Liability, Noncurrent 12.9M USD -11.9%
Liabilities 84.5M USD +4.32%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -520M USD -6.1%
Stockholders' Equity Attributable to Parent 9.89M USD -53.4%
Liabilities and Equity 94.4M USD -7.67%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.53M USD +22.4%
Net Cash Provided by (Used in) Financing Activities 72K USD
Net Cash Provided by (Used in) Investing Activities 2.4M USD -76.2%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 29.1M shares +12.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.06M USD -4500%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13M USD +62.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.17M USD +15.3%
Deferred Tax Assets, Valuation Allowance 72.3M USD +11.6%
Deferred Tax Assets, Gross 75.7M USD +10.2%
Operating Lease, Liability 14.6M USD -9.4%
Depreciation 169K USD -28.1%
Payments to Acquire Property, Plant, and Equipment 104K USD -21.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -29.9M USD +29%
Lessee, Operating Lease, Liability, to be Paid 18.8M USD -13.1%
Property, Plant and Equipment, Gross 8.87M USD -9.49%
Operating Lease, Liability, Current 1.74M USD +14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.03M USD +3.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.94M USD +2.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.11M USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.12M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 41.9M USD +2.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.73M USD +8.06%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.22M USD +2.98%
Operating Lease, Payments 700K USD 0%
Additional Paid in Capital 530M USD +3.63%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 9.87M USD +9.16%
Interest Expense 8.81M USD +15%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%